Jessica M. Marbourg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jessica M. Marbourg has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Adrienne M. Dorrance
Comprehensive Cancer Center, The Ohio State University, Columbus, USA
1 shared publication- Antigona Ulndreaj
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada
1 shared publication - Faith H. Brennan
The Ohio State University
1 shared publication - Jodie C. E. Hall
The Ohio State University
1 shared publication - Katherine A. Mifflin
Department of Neuroscience, Belford Center for Spinal Cord Injury, Centre for Brain and Spinal Cord Repair, The Ohio State University; Columbus, Ohio, 43210, USA
1 shared publication Malith Karunasiri
Comprehensive Cancer Center, The Ohio State University, Columbus, USA
1 shared publication
Latest Publications
- Open Access
- 24 July 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-13
Spinal cord injury causes chronic bone marrow failure
Spinal cord injury (SCI) causes immune dysfunction, increasing the risk of infectious morbidity and mortality. Since bone marrow hematopoiesis is essential for proper immune function, we hypothesize that SCI disrupts bone marrow hematopoiesis. Indeed, SCI causes excessive proliferation of bone marrow hematopoietic stem and progenitor cells (HSPC), but these cells cannot leave the bone marrow, even after challenging the host with a potent inflammatory stimulus. Sequestration of HSPCs in bone marrow after SCI is linked to aberrant chemotactic signaling that can be reversed by post-injury injections of Plerixafor (AMD3100), a small molecule inhibitor of CXCR4. Even though Plerixafor liberates HSPCs and mature immune cells from bone marrow, competitive repopulation assays show that the intrinsic long-term functional capacity of HSPCs is still impaired in SCI mice. Together, our data suggest that SCI causes an acquired bone marrow failure syndrome that may contribute to chronic immune dysfunction.
- 24 July 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-13
Open AccessSpinal cord injury causes chronic bone marrow failure
Spinal cord injury (SCI) causes immune dysfunction, increasing the risk of infectious morbidity and mortality. Since bone marrow hematopoiesis is essential for proper immune function, we hypothesize that SCI disrupts bone marrow hematopoiesis. Indeed, SCI causes excessive proliferation of bone marrow hematopoietic stem and progenitor cells (HSPC), but these cells cannot leave the bone marrow, even after challenging the host with a potent inflammatory stimulus. Sequestration of HSPCs in bone marrow after SCI is linked to aberrant chemotactic signaling that can be reversed by post-injury injections of Plerixafor (AMD3100), a small molecule inhibitor of CXCR4. Even though Plerixafor liberates HSPCs and mature immune cells from bone marrow, competitive repopulation assays show that the intrinsic long-term functional capacity of HSPCs is still impaired in SCI mice. Together, our data suggest that SCI causes an acquired bone marrow failure syndrome that may contribute to chronic immune dysfunction.
- Open Access
- 9 September 2015
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 35 (36) , 12325-12327
The Complement Receptor C5aR Has a Dual, Time-Dependent Effect on the Outcome of Spinal Cord Injury
The complement system consists of more than 30 plasma and membrane-bound proteins that promote host defense by inducing cell lysis, disposing of immune complexes, and augmenting the adaptive immune response. Under homeostatic conditions, these complement proteins are expressed by all the cells of
- 9 September 2015
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 35 (36) , 12325-12327
Open AccessThe Complement Receptor C5aR Has a Dual, Time-Dependent Effect on the Outcome of Spinal Cord Injury
The complement system consists of more than 30 plasma and membrane-bound proteins that promote host defense by inducing cell lysis, disposing of immune complexes, and augmenting the adaptive immune response. Under homeostatic conditions, these complement proteins are expressed by all the cells of